Main Article Content
Aims: The aim of this study was to evaluate the efficacy of laser photocoagulation for type 1 idiopathic macular telangiectasia (MacTel).
Study Design: Retrospective case series
Place and Duration of Study: Department of Ophthalmology, Oita University Hospital during the period from 2004 to 2013.
Patients and Methods: Six eyes of 6 patients with type 1 MacTel diagnosed consecutively in the Oita University Hospital during the period from 2004 to 2013 were studied. They showed macular edema and their visual acuity were deteriorated due to leakage from the aneurysms. Four patients were male and two were female with an average age of 64 years (range: 41 to 74 years). Informed consent was obtained from each patient and the laser photocoagulation was applied to leaky aneurysms in all eyes. The central macular thickness (CMT) was measured by optical coherence tomography (OCT). Mean follow up period was 44 months (range: 24 - 63 months).
Results: Mean visual acuity significantly increased from logMAR 0.25±0.27 at baseline to logMAR 0.11±0.14 (P<0.05) at the last visit. Visual acuity improved more than 0.2 logMAR in five eyes and was stable (gain or loss of < 0.3 logMAR) in one eye. Mean central macular thickness significantly decreased from 454±181 μm at baseline to 231±67 μm (P<0.05) at the last visit. Macular edema was not detected by OCT inany patients at the last visit.
Conclusion: In type I MacTel, laser photocoagulation may achieve a visual improvement and normalize the central macular thickness.
Yannuzzi LA, Bardal AM, Freund B, Chen K-J, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch Ophthalmol 2006;24: 450-60.
Stoffelns BM, Schoepfer K, Kramann C. Idiopathic macular telangiectasia -follow-up with and without laser photocoagulation. Klin Monbl Augenheilkd. 2010;227:252-6.
Maruko I, Iida T, Sugano Y, Ojima A, Oyamada H, Sekiryu T. Demographic features of idiopathic macular telangiectasia in Japanese patients. Jpn J Ophthalmol. 2012;56:152-8.
Kono H, Kishi D, Kimoto K, Kubota T. The efficacy of laser photocoagulation for type 1 Idiopathic macular telangiectasia. Investigative Ophthalmology & Visual Science.2012;26;53(14):5205.
Takeda M, Imaizumi H, Okushiba U. Laser photocoagulation for idiopathic juxtafoveal retinal telangiectasia. Folia Ophthalmol Jpn. 1997;48:172-7.
Toriyama Y, Katai N, Kojima H, Yoshimura N. Eleven cases of idiopathic juxtafoveolar telangiectasis. Folia Ophthalmol Jpn 1999;50:244−7.
Yoshitake K, Hideo M. Four cases of idiopathic juxtafoveolar retinal telangiectasia. Rinsho Ganka (Jpn J Clin Ophthalmol). 2006;60:1163-8.
Jinza K, Tanaka T, Saika S, Ohnishi Y. Clinical and optical coherence tomographic features in a case of juxtafoveolar retinal telangiectasis resistant to photo coagulation. Folia Ophthalmol Jpn. 2001; 95:260-2.
Hirano Y, Yasukawa T, Usui Y, Nozaki M, Ogura Y. Indocyanine green angiography-guided laser photocoagulation combined with sub-tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia. Br J Ophthalmol. 2010;94:600-5.
Takayama K, Ooto S, Tamura H, Yamashiro K, Otani A, Tsujikawa A, et al. Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia. Eye (Lond). 2010;24:1492-7.
Matsumoto Y, Yuzawa M. Intravitreal bevacizumab therapy for idiopathic macular telangiectasia. Jpn J Ophthalmol. 2010;54:320-4.
Hirano T, Toriyama Y, Iesato Y, Imai A, Hirabayashi K, Nagaoka T, et al. Effect of leaking microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation. Jpn J Ophthalmol. 2017;61:51-60.
Moon BG, Kim YJ, Yoon YH, Lee JY. Use of intravitreal bevacizumab injections to treat type 1 idiopathic macular telangiectasia. Graefe’s Arch Clin Exp Ophthalmol. 2012;250:1697-9.
Kowalczuk L, Matet A, Dirani A, Daruich A, Ambresin A, Mantel I, et al. Efficacy of intravitreal aflibercept in macular telangiectasia type 1 is linked to the ocular angiogenic profile. Retina 2017;37:2226-37.